Welcome to Hogrefe Publishing,

How is suicide portrayed in the cinema and what does it mean for suicide prevention? The first-ever comprehensive study of film suicide analyzes more than 1,500 film suicides. The portrayal of suicide in cinema can impact public understanding and effective prevention of suicide. This book presents the first-ever comprehensive analysis of how suicide has been portrayed in films over 110 years, based on a thorough evaluation of more than 1,500 film suicides – 1,377 in American films, 135 in British films. One striking finding is that while the research literature generally attributes suicide to individual psychiatric or mental health issues, cinema and film solidly endorse more social causes. In a compelling blend of social science and humanities approaches, the authors use quantitative methods, as well as the voices of scriptwriters, directors, actors, and actresses, dozens of illustrative frame-grabs, and numerous case examples to answer core questions such as: Are we guilty of over-neglecting social factors in suicide prevention and research? Do cinematic portrayals distort or accurately reflect the nature of suicide in the real world? Has film presentation of suicide changed over 110 years? What are the literary roots of cinema portrayals? This unique book makes fascinating reading for all concerned with suicide prevention, as well as areas such as sociology, film and media studies, and mass communication.

Fully updated and expanded, in full color with intuitive icons throughout, packed with new and expanded comparison charts, and now with patient handouts as printable PDFs – the classic reference to psychotropic medications is now more “user-friendly” than ever! The Clinical Handbook of Psychotropic Drugs has become a standard reference and practical tool for psychiatrists, psychiatric nurses, pharmacists, psychologists, physicians, and all mental health professionals. The new and fully updated 19th edition retains all the practical features for which the Clinical Handbook is renowned:
- Independent, unbiased
- Packed with unique comparison charts (dosages, side effects, pharmacokinetics, interactions…) that allow you to see at a glance which medication is the most suitable for each patient
- Instantly recognizable icons and full color throughout, allowing you to find at a glance all the information you seek
- The latest information on newly released drugs, adverse effects, approved indications (see below for details)
- Succinct, bulleted information on all classes of medication: on- and off-label indications, side effects, interactions, pharmacodynamics, precautions in the young, the elderly, and pregnancy, nursing implications, and much more – all you need to know for each class of drug
- Patient Handouts, Herbal and “Natural” Products, Unapproved Treatments, ECT, BLT, rTMS. New in this edition:
- Pharmacotherapy for nicotine/tobacco use
- Extensive revisions and additions to the antipsychotics, including dosing, adverse effects, interactions, precautions
- New dosage/pharmacokinetics comparison chart for extrapyramidal agents
- Extensive revisions to benzodiazepines and hypnotics/sedatives comparison chart
- Updates on unapproved treatments (e.g., pregabalin and vigabatrin for alcohol and cocaine dependence) and herbal and “natural” products (e.g., for treatment of depression) - Hundreds of new references
- Printable (PDF) patient handouts
- Drugs with recent/changed approval include: lurasidone (Latuda), vilazodone (Viibryd), iloperidone (Fanapt), asenapine sublingual (Saphris), guanfacine (Tenex, Intuniv), degarelix (Firmagon), finasteride (Proscar)
- Preparations added include: Symbyax, Prozac Weekly, Luvox CR, Aplenzin, Oleptro, Silenor, Zonolon, Invega Sustenna, Zyprexa Relprevv, Mellaril, Compoz, Epitol, Teril, Nytol, Simply Sleep, Sominex, Unisom, clonidine SR (Kapvay)